An innovative service company focusing on the field of drug quality control


Contact Us

You are here:Home >> News >> Company News

Company News

Today Recommend Impurities of Dapagliflozin

Time:2022-07-22 Views:55
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This class of drug uses the kidneys to help control your glucose (blood sugar) levels. It works by increasing the amount of glucose removed from the body when you urinate. It was first approved by the US Food and Drug Administration (FDA) in 2014.
The following are some of the impurities of Dapagliflozin: